Showing results (341-350 of 349) with videos related to
Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 349 results.
Circulation|April 4, 2022
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical TrialDuk-Woo Park, Jung-Min Ahn, Do-Yoon Kang, et al.Korean Circulation Journal|April 7, 2022
Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure TargetsDae-Hee Kim, In-Jeong Cho, Woohyeun Kim, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|January 25, 2021
Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in koreaMi-Hyang Jung, Ju-Hee Lee, Chan Joo Lee, et al.Journal of the American Heart Association|March 15, 2021
Disparities in Mortality and Cardiovascular Events by Income and Blood Pressure Levels Among Patients With Hypertension in South KoreaJeong-Hun Shin, Mi-Hyang Jung, Chang Hee Kwon, et al.Journal of Cardiovascular Ultrasound|November 3, 2017
Current Awareness and Use of the Strain Echocardiography in Routine Clinical Practices: Result of a Nationwide Survey in KoreaJu-Hee Lee, Jae-Hyeong Park, Seung Woo Park, et al.American Heart Journal|December 20, 2023
Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trialMijin Kim, Jung-Min Ahn, Do-Yoon Kang, et al.Cardiovascular Diabetology|October 20, 2020
Blood pressure levels and cardiovascular risk according to age in patients with diabetes mellitus: a nationwide population-based cohort studyHack-Lyoung Kim, Hyue Mee Kim, Chang Hee Kwon, et al.Journal of the American Heart Association|March 19, 2021
Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South KoreaChang Hee Kwon, Woohyeun Kim, Jeong-Hun Shin, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|May 14, 2026
Low-Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III TrialHyo-Suk Ahn, Jeong-Cheon Ahn, Jin-Man Cho, et al.Pageof 35